Correspondence 0001641172-25-002904 from Caring Brands, Inc. (CABR)
Caring Brands, Inc.
Date: April 7, 2025 · CIK: 0002020737 · Accession: 0001641172-25-002904
AI Filing Summary & Sentiment
File numbers found in text: 333-285964
Referenced dates: April 2, 2025
Show Raw Text
CORRESP
1
filename1.htm
April
7, 2025
Securities
and Exchange Commission
Division
of Corporate Finance
100
F Street, NE
Washington,
D.C. 20549
Attn:
Mr. Robert Augustin and Ms. Jane Park
Re:
Caring Brands, Inc.
Registration
Statement on Form S-1
Filed
March 20, 2025
File
No. 333-285964
Dear
Mr. Augustin and Ms. Park:
Please
find below our responses to the questions raised by the staff (the " Staff ") of the Securities and Exchange Commission
(the " Commission ") in its letter of comments dated April 2, 2025 (the " Comment Letter") relating
to the registration statement on Form S-1, which was filed with the Commission by Caring Brands, Inc. (the " Company "
or " we ") on March 20, 2025.
The
Company's responses are numbered to correspond to the Staff's comments. For your convenience, each of the Staff's comments
contained in the Comment Letter has been restated in bold .
We
have also updated the Registration Statement on Form S-1 (" Registration Statement ") which is submitted to the Commission
simultaneously together with this letter.
Registration
Statement on Form S-1 filed March 20, 2025
Index
to consolidated financial Statements page F-1
1.
As
the financial statements are now as of a date after the merger and given the nature of the two companies and the transaction, it
appears appropriate to include one set of consolidated financial statements for the combined entity. In presenting operations prior
to the merger, we remind you that the determination of the accounting acquirer under ASC 805 is different from the determination
of whether there is a predecessor entity pursuant to Rule 405 of Regulation C. Because of the insignificant operations of CBI NV
and the change in focus to the ongoing business of CBI FL, it appears that CBI FL would be the predecessor entity prior to the September
2024 transaction. As a result, we would expect the premerger historical financial statements of the consolidated entity to be the
historical financial statements of CBI FL only. The premerger results of operations of CBI NV should no longer be presented. The
pro forma financial statements would appear to no longer be required. Please revise the financial statements as necessary or provide
a comprehensive analysis of how you determined that CBI FL would not be the predecessor entity pursuant to Rule 405 of Regulation
C.
Response :
The Company has revised its financial statements to reflect the appropriate Predecessor and Successor information consistent
with the comment of the staff. The Company referred to Section 1170 of the SEC Reporting Manual to make its modifications.
In
addition, we have added language as to the Company's belief with respect to the statistical significance of the p-values
in the clinical studies discussion on page 42. Should you have any questions regarding the foregoing, please do not hesitate to
contact me or our counsel with any questions or comments regarding this correspondence on the revised and updated Registration Statement.
Very
truly yours,
By:
/s/
Glynn Wilson
Name:
Glynn
Wilson
Chief
Executive Officer